Efficacy and Safety of Kangfuxin Liquid Adjuvant Therapy Versus Standard Dressing in Treating Stage II–III Pressure Ulcers: A Meta-Analysis of Randomized Controlled Trials
Restricted accessReview articleFirst published online 2026
Efficacy and Safety of Kangfuxin Liquid Adjuvant Therapy Versus Standard Dressing in Treating Stage II–III Pressure Ulcers: A Meta-Analysis of Randomized Controlled Trials
Kangfuxin Liquid, with properties of promoting tissue repair, anti-inflammation, and bacteriostasis, requires systematic evaluation regarding its efficacy and safety in adjuvant treatment of pressure ulcers.
Methods
Databases including PubMed, Embase, Cochrane Library, CNKI, and Wanfang were searched for randomized controlled trials (RCTs) published from January 2015 to June 2025, comparing Kangfuxin Liquid adjuvant therapy with standard dressing in treating stage II–III pressure ulcers. Two researchers independently screened literature, extracted data, and evaluated quality. Meta-analysis was performed using RevMan 5.4 software. Outcome indicators included wound healing rate, healing time, wound area reduction rate after 2 weeks of treatment, and adverse reaction rate.
Results
A total of 12 RCTs involving 886 patients were included, with 450 patients in the experimental group (Kangfuxin Liquid + standard dressing) and 436 in the control group (standard dressing alone). Meta-analysis showed that the experimental group had significantly higher wound healing rate [RR = 1.44, 95% CI (1.32, 1.56), P < 0.0001, I2 = 79.4%], significantly shorter healing time [MD = −6.77 days, 95% CI (−7.22, −6.32), P < 0.0001, I2 = 82.8%], significantly increased wound area reduction rate after 2 weeks of treatment [MD = 19.02%, 95% CI (17.94, 20.09), P < 0.0001, I2 = 81.7%], and a lower adverse reaction rate with no statistically significant difference [RR = 0.73, 95% CI (0.47, 1.12), P = 0.15, I2 = 83.2%]. Kangfuxin Liquid adjuvant therapy is well-tolerated with a favorable safety profile, as adverse events in the control group were mostly infection-related, while those in the KFX group were mild local irritation.
Conclusion
Kangfuxin Liquid adjuvant therapy can significantly improve wound healing rate, shorten healing time, promote wound reduction, and ensure high safety in treating stage II–III pressure ulcers, which is worthy of clinical promotion.
ViscontiAJSolaOIRaghavanPV. Pressure injuries: Prevention, evaluation, and management. Am Fam Physician. 2023;108(2):166-174. PMID: 37590857.
2.
HillJEEdneySHamerO, et al.Interventions for the treatment and prevention of pressure ulcers. Br J Community Nurs. 2022;27(Sup6):S28-S36. PMID: 35671199. doi:10.12968/bjcn.2022.27.Sup6.S28
3.
GrigattiAGefenA. The biomechanical efficacy of a hydrogel-based dressing in preventing facial medical device-related pressure ulcers. Int Wound J. 2022;19(5):1051-1063. PMID: 34623747. doi:10.1111/iwj.13701
4.
YuSYUllrichPJWeissmanJP, et al.Evaluation of altrazeal transforming powder dressing on stage 2-4 pressure ulcers: A clinical case series. J Wound Care. 2022;31(Sup5):S6-S12. PMID: 35576191. doi:10.12968/jowc.2022.31.Sup5.S6
5.
MoserCHPeelerALongR, et al.Prevention of endotracheal tube-related pressure injury: A systematic review and meta-analysis. Am J Crit Care. 2022;31(5):416-424. PMID: 36045033. doi:10.4037/ajcc2022644
6.
GrigattiAGefenA. What makes a hydrogel-based dressing advantageous for the prevention of medical device-related pressure ulcers. Int Wound J. 2022;19(3):515-530. PMID: 34245120. doi:10.1111/iwj.13650
7.
GengJCaiYLuH, et al.Moist dressings in the treatment of pressure injuries: A network meta-analysis. J Tissue Viability. 2023;32(2):213-227. PMID: 37012127. doi:10.1016/j.jtv.2023.03.003
8.
ZhangCZhangSWuB, et al.Efficacy of different types of dressings on pressure injuries: Systematic review and network meta-analysis. Nurs Open. 2023;10(9):5857-5867. PMID: 37386786. doi:10.1002/nop2.1867
9.
ShiJGaoYTianJ, et al.Negative pressure wound therapy for treating pressure ulcers. Cochrane Database Syst Rev. 2023;5(5):CD011334. PMID: 37232410. doi:10.1002/14651858.CD011334.pub3
10.
ChenYRYangXFDingXJ, et al.Efficacy and safety of Kangfuxin liquid for eczema: A systematic review and meta-analysis. Arch Dermatol Res. 2025;317(1):608. PMID: 40111524. doi:10.1007/s00403-025-03983-9
11.
LinXChuJXiangY, et al.Kangfuxin liquid reduces the ultraviolet B-induced photodamage of HaCaT cells by regulating autophagy. Biosci Biotechnol Biochem. 2023;87(12):1485-1494. PMID: 37682516. doi:10.1093/bbb/zbad130
12.
SunWJianYFengX, et al.Efficacy of Kangfuxin liquid for preventing and treating chemotherapy-induced oral mucositis: A systematic review and meta-analysis of randomized controlled trials. Front Pharmacol. 2025;16:1565345. PMID: 40264666. doi:10.3389/fphar.2025.1565345
13.
TangMNiLLXuJL, et al.Kangfuxin liquid ameliorates dextran sulfate sodium (DSS)-induced acute ulcerative colitis in mice by modulating immune response and suppressing inflammation. Med Sci Monit Basic Res. 2021;27:e930887. PMID: 33972494. doi:10.12659/MSMBR.930887
14.
MaJYangYCSuLQ, et al.The liquid Kangfuxin (KFX) has efficient antifungal activity and can be used in the treatment of vulvovaginal candidiasis in mice. Lett Appl Microbiol. 2022;74(4):564-576. PMID: 34958703. doi:10.1111/lam.13641
15.
YuanHSuJTanJ, et al.Efficacy of kangfuxin liquid on radiotherapy-induced oral mucositis for patients with head and neck squamous cell carcinoma and its effect on salivary glands and immune function. Am J Transl Res. 2022;14(9):6792-6804. PMID: 36247271.
16.
WangTLuHLiF, et al.Effect of Kangfuxin Liquid enema combined with mesalazine on gestational outcomes and quality of life in child-bearing female with active ulcerative colitis: A protocol for randomized, double-blind, controlled trial. Medicine (Baltimore). 2021;100(5):e23915. PMID: 33592841. doi:10.1097/MD.0000000000023915
17.
WanXGenFShengY, et al.Meta-Analysis of the effect of kangfuxin liquid on diabetic patients with skin ulcers. Evid Based Complement Alternat Med. 2021;2021:1334255. PMID: 34122591. doi:10.1155/2021/1334255
18.
SunHYangCLiuX, et al.Effectiveness of negative pressure wound therapy of diabetic foot ulcers using periplaneta Americana (Kangfuxin liquid) irrigation. Int J Low Extrem Wounds. 2025;24(4):15347346231176917. PMID: 37203153. doi:10.1177/15347346231176917
19.
ZhaoJWangY. A comparative observation on wound healing after surgery for necrotizing fasciitis: Kangfuxin liquid gauze versus vaseline gauze. Altern Ther Health Med. 2024;30(5):33-39. PMID: 38294741.
20.
LiHBChenMYQiuZW, et al.Efficacy and safety of Kangfuxin liquid combined with aminosalicylic acid for the treatment of ulcerative colitis: A systematic review and meta-analysis. Medicine (Baltimore). 2018;97(21):e10807. PMID: 29794765. doi:10.1097/MD.0000000000010807
21.
BanksMDWebsterJBauerJ, et al.Effect of supplements/intensive nutrition on pressure ulcer healing: A multicentre, randomised controlled study. J Wound Care. 2023;32(5):292-300. PMID: 37094924. doi:10.12968/jowc.2023.32.5.292
22.
PittmanJGillespieC. Medical device-related pressure injuries. Crit Care Nurs Clin North Am. 2020;32(4):533-542. PMID: 33129412. doi:10.1016/j.cnc.2020.08.004
23.
ZajacKKSchubauerKSimmanR. The unavoidable pressure injury/ulcer: A review of skin failure in critically ill patients. J Wound Care. 2024;33(Sup9):S18-S22. PMID: 39283888. doi:10.12968/jowc.2024.0079
KashkouliMBKhademiBErfanian-SalimR, et al.Pressure ulcer following circumferential head dressing. Orbit. 2020;39(5):350-356. PMID: 31997676. doi:10.1080/01676830.2020.1719521
26.
BrienzaDGefenAClarkM, et al.The vision and scope of the prophylactic dressing standard initiative of the European Pressure Ulcer Advisory Panel and National Pressure Injury Advisory Panel. Int Wound J. 2022;19(5):963-964. PMID: 35698857. doi:10.1111/iwj.13859
27.
HahnelEEl GenedyMTomova-SimitchievaT, et al.The effectiveness of two silicone dressings for sacral and heel pressure ulcer prevention compared with no dressings in high-risk intensive care unit patients: A randomized controlled parallel-group trial. Br J Dermatol. 2020;183(2):256-264. PMID: 31628863. doi:10.1111/bjd.18621
28.
MoserCHPeelerALongR, et al.Prevention of tracheostomy-related pressure injury: A systematic review and meta-analysis. Am J Crit Care. 2022;31(6):499-507. PMID: 36316177. doi:10.4037/ajcc2022659
29.
LyuYHuangYLLiZY, et al.Interventions and strategies to prevent medical device-related pressure injury in adult patients: A systematic review. J Clin Nurs. 2023;32(19-20):6863-6878. PMID: 37300246. doi:10.1111/jocn.16790
30.
OeMSasakiSShimuraT, et al.Effects of multilayer silicone foam dressings for the prevention of pressure ulcers in high-risk patients: A randomized clinical trial. Adv Wound Care (New Rochelle). 2020;9(12):649-656. PMID: 33124968. doi:10.1089/wound.2019.1002
31.
LovegroveJFulbrookPMilesS, et al.Effectiveness of interventions to prevent pressure injury in adults admitted to intensive care settings: A systematic review and meta-analysis of randomised controlled trials. Aust Crit Care. 2022;35(2):186-203. PMID: 34144863. doi:10.1016/j.aucc.2021.04.007
32.
ForniCSearleR. A multilayer polyurethane foam dressing for pressure ulcer prevention in older hip fracture patients: An economic evaluation. J Wound Care. 2020;29(2):120-127. PMID: 32058851. doi:10.12968/jowc.2020.29.2.120
33.
LiDFeiXXuL, et al.Pressure-sensitive antibacterial hydrogel dressing for wound monitoring in bed ridden patients. J Colloid Interface Sci. 2022;627:942-955. PMID: 35901575. doi:10.1016/j.jcis.2022.07.030
34.
Malek HosseiniARostam KhaniMAbdiS, et al.Comparison of aloe vera gel dressing with conventional dressing on pressure ulcer pain reduction: A clinical trial. BMC Res Notes. 2024;17(1):25. PMID: 38229162. doi:10.1186/s13104-023-06682-8
35.
EberhardtTDde LimaSBSde Avila SoaresRS, et al.Prevention of pressure injury in the operating room: Heels operating room pressure injury trial. Int Wound J. 2021;18(3):359-366. PMID: 33314605. doi:10.1111/iwj.13538
36.
SillmonKMoranCShookL, et al.The use of prophylactic foam dressings for prevention of hospital-acquired pressure injuries: A systematic review. J Wound Ostomy Continence Nurs. 2021;48(3):211-218. PMID: 33951710. doi:10.1097/WON.0000000000000762
37.
LatimerSWalkerRMChaboyerW, et al.Prophylactic dressings to prevent sacral pressure injuries in adult patients admitted to intensive care units: A three-arm feasibility randomized controlled trial. Intensive Crit Care Nurs. 2024;84:103746. PMID: 38896962. doi:10.1016/j.iccn.2024.103746
38.
PattonDMooreZEBolandF, et al.Dressings and topical agents for preventing pressure ulcers. Cochrane Database Syst Rev. 2024;12(12):CD009362. PMID: 39625073. doi:10.1002/14651858.CD009362.pub4
39.
O'BrienNMooreZAvsarP, et al.The impact of healthcare assistant education on pressure ulcer prevention: A systematic review. J Wound Care. 2023;32(Sup7a):cxv-cxxvii. PMID: 37405970. doi:10.12968/jowc.2023.32.Sup7a.cxv
40.
AvsarPMooreZPattonD. Dressings for preventing pressure ulcers: How do they work?J Wound Care. 2021;30(1):33-39. PMID: 33439083. doi:10.12968/jowc.2021.30.1.33
